Browsing by Author Arthur, Christopher

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 3 of 3
Issue DateTitleAuthor(s)Citation
2017Clinical, cellular, microscopic, and ultrastructural studies of a case of fibrogenesis imperfecta ossiumBarron, Melissa; Clifton-Bligh, Phillip; Clifton-Bligh, Roderick; Mason, Rebecca; Ramesh (Sivagurunathan), Sutharshani; Rybchyn, Mark; Arthur, Christopher; Bonar, S. Fiona; Hudson, Bernie; Khosla, Sundeep; Kim, Edward; Stalley, Paul; School of Medical Sciences: Physiology; Northern Clinical School: Medicine; Northern Clinical School: Medicine; School of Medical Sciences: Physiology; School of Medical Sciences: Physiology; School of Medical Sciences: PhysiologyClinical, cellular, microscopic, and ultrastructural studies of a case of fibrogenesis imperfecta ossium, Bone Research, vol.5, 14, 2017,pp 1-14
2015An imatinib-only window followed by imatinib and chemotherapy for Philadelphia chromosome-positive acute leukemia: long-term results of the CMLALL1 trialBradstock, Kenneth; Arthur, Christopher; Durrant, Simon; et al, Various; Filshie, Robin; Grigg, Andrew P.; Hughes, Timothy P; Irving, Ian; Lickliter, Jason D; Szer, Jeffrey; Taylor, Kerry; Western Clinical School: Westmead Institute for Medical ResAn imatinib-only window followed by imatinib and chemotherapy for Philadelphia chromosome-positive acute leukemia: long-term results of the CMLALL1 trial, Leukemia & Lymphoma, vol.56, 3, 2015,pp 630-638
2017Serum levels, safety and tolerability of new formulation SUBA-itraconazole prophylaxis in patients with haematological malignancy or undergoing allogeneic stem cell transplantationGreenwood, Matthew; Kerridge, Ian; Stevenson, William; Arthur, Christopher; Coyle, Luke; Fay, Keith; Lindsay, Julian; Sandaradura, Indy; Wong, Kelly; Northern Clinical School: Kolling Institute; School of Public Health: Ctr for Values Ethics & Law in Med; Northern Clinical School: MedicineSerum levels, safety and tolerability of new formulation SUBA-itraconazole prophylaxis in patients with haematological malignancy or undergoing allogeneic stem cell transplantation, Journal of Antimicrobial Chemotherapy, vol.72, 12, 2017,pp 3414-3419